Context · Geopolitics · sweep Tuesday, November 17, 2026
Measles resurgence in the US and loss of elimination status
Measles exceeds 5,000 cases in the US for the first time since 1991 and the country is about to lose its 26-year elimination status, with fatal outbreaks concentrated in Pennsylvania. The dynamic exposes the collapse of vaccination coverage as a public health failure with regulatory and school infrastructure consequences, not an isolated health event.
Title, thesis and gravity assessment written by an AI model, without prior human review.
Gravity58/100 · Context
Why this gravity
El cluster documenta un hito de salud pública (más de 5,000 casos, primero desde 1991, y pérdida inminente del estatus de eliminación de 26 años) pero los artículos representativos son actualizaciones incrementales del conteo del CDC (4,080 → 4,588 → 4,852) sin una discontinuidad material fechada hoy; el impacto regulatorio y de política vacunal es de evolución lenta, no un evento que obligue reposicionamiento inmediato de capital.
- Coverage
- 4 feeds · 4 independent publisher groups (corroborated)
- Cross verticals
- Geopolitics, Lifespan & Healthspan, EdTech
- Gravity vs. the previous edition
- +13 (45 → 58)
coverage, not accuracy
Lead source
US measles cases rise to 4,080, CDC says - Reuters · Reuters LegalMore: The 74, STAT News, Education Week
Timeline · Madrid time
- 13:53How big is Pennsylvania’s measles outbreak? · STAT News
- 22:19
- 19:45US measles cases rise to 4,080, CDC says - Reuters · Reuters Legal
- 19:39
- 19:27CDC reports 4,410 measles cases as outbreak grows - Reuters · Reuters Legal
- 19:33
- 16:41Measles Has Come Back in Force. Is Your School Ready? · Education Week
- 19:28
- 19:35
- 02:51
- 21:25US measles cases rise to 4,852, CDC says - Reuters · Reuters Legal
- 14:48
- 21:31
- 20:33
- 20:35
- 13:56
- 23:20
- 01:55
- 17:14
ShareWhatsApp
Related stories
- 0European and Japanese space exploration of the deep solar system
- 82Reconfiguration of private capital in the US healthcare sector
- 82Attacks with AI agents and regulatory response in Asia
- 82Pharmaceutical agreements between China and the West and R&D relocation
- 80Binance security breach and insurer scrutiny of crypto exchanges